dc.contributor.author | Karacin, Cengiz | |
dc.contributor.author | Öksüzoğlu, Berna | |
dc.contributor.author | Demirci, Ayşe | |
dc.contributor.author | Keskinkılıç, Merve | |
dc.contributor.author | Köse Baytemur, Naziyet | |
dc.contributor.author | Yılmaz, Funda | |
dc.contributor.author | Selvi, Oğuzhan | |
dc.contributor.author | Hacıbekiroğlu, İlhan | |
dc.date.accessioned | 2023-03-27T07:48:47Z | |
dc.date.available | 2023-03-27T07:48:47Z | |
dc.date.issued | 2023 | en_US |
dc.identifier.citation | Karacin, C., Öksüzoğlu, B., Demirci, A., Keskinkılıç, M., Köse Baytemur, N., Yılmaz, F. ... Hacıbekiroğlu, İ. (2023). Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023). BMC Cancer, 23(1). https://dx.doi.org/10.1186/s12885-023-10662-3 | en_US |
dc.identifier.issn | 1471-2407 | |
dc.identifier.uri | https://dx.doi.org/10.1186/s12885-023-10662-3 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/10700 | |
dc.description.abstract | Following publication of the original article [1], the authors reported an error in the author name of Enes Erul. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | BMC | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | CDK 4/6 Inhibitor Therapy | en_US |
dc.subject | Breast Cancer | en_US |
dc.subject | Disease Progression | en_US |
dc.title | Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023) | en_US |
dc.title.alternative | Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (BMC Cancer, (2023), 23, 1, (136), 10.1186/s12885-023-10609-8) | en_US |
dc.type | other | en_US |
dc.relation.ispartof | BMC Cancer | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | en_US |
dc.identifier.volume | 23 | en_US |
dc.identifier.issue | 1 | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.identifier.doi | 10.1186/s12885-023-10662-3 | en_US |
dc.institutionauthor | Sakin, Abdullah | |
dc.identifier.wosquality | Q2 | en_US |
dc.identifier.wos | 000941147400001 | en_US |
dc.identifier.scopus | 2-s2.0-85148970683 | en_US |
dc.identifier.pmid | 36849943 | en_US |
dc.identifier.scopusquality | Q2 | en_US |